Pages that link to "Q73933454"

The following pages link to Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4 (Q73933454):

Displaying 16 items.

• A numerical method for analysis of in vitro time-dependent inhibition data. Part 1. Theoretical considerations (Q30831869) (← links)
• General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs (Q34656231) (← links)
• Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon (Q35129382) (← links)
• Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4. (Q35166632) (← links)
• Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. (Q36068699) (← links)
• Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review (Q37824590) (← links)
• Predicting drug interaction potential with a physiologically based pharmacokinetic model: a case study of telithromycin, a time-dependent CYP3A inhibitor (Q39643626) (← links)
• The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling (Q40091284) (← links)
• Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors (Q40529215) (← links)
• In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A. (Q43220404) (← links)
• Effect of the fluoroquinolone antibacterial agent DX-619 on the apparent formation and renal clearances of 6β-hydroxycortisol, an endogenous probe for CYP3A4 inhibition, in healthy subjects (Q43615344) (← links)
• High-throughput screening for the assessment of time-dependent inhibitions of new drug candidates on recombinant CYP2D6 and CYP3A4 using a single concentration method (Q44522113) (← links)
• Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats (Q44852643) (← links)
• Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate (Q46896462) (← links)
• A Physiologically Based Pharmacokinetic Model Characterizing Mechanism-based Inhibition of CYP1A2 for Predicting Theophylline/Antofloxacin Interaction in both Rats and Humans (Q83930374) (← links)
• Consideration of Reliable Concentrations for Prediction of Change in Enzyme Activity by Mechanism-based Inactivation Using Physiologically-based Pharmacokinetic Model Simulations (Q84977045) (← links)